39 related articles for article (PubMed ID: 34659977)
1. Primary Cutaneous B-cell Lymphomas: Case Report of Two Cases.
Mishra S; Shelly D; Vinu Balraam KV; Bharadwaj R
Indian J Dermatol; 2017; 62(6):675. PubMed ID: 29263552
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions.
Suárez AL; Querfeld C; Horwitz S; Pulitzer M; Moskowitz A; Myskowski PL
J Am Acad Dermatol; 2013 Sep; 69(3):343.e1-11; quiz 355-6. PubMed ID: 23957985
[TBL] [Abstract][Full Text] [Related]
3. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
4. A Perplexing Case of Recurrent Abscess-Like Lesions: Insights Into Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
Bin Waqar SH; Zaman U; Salahi N; Gupta R; McFarlane IM
Cureus; 2021 Sep; 13(9):e17766. PubMed ID: 34659977
[TBL] [Abstract][Full Text] [Related]
5. Germinal Centre-Related Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type: Report of a Remission Case.
Liu F; Qi F; Zhang X; Cao M; Peng S
Clin Cosmet Investig Dermatol; 2022; 15():1265-1269. PubMed ID: 35821763
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type with significant T-cell immune response.
Graham PM; Richardson AS; Schapiro BL; Saunders MD; Stewart DM
JAAD Case Rep; 2018 May; 4(4):305-309. PubMed ID: 29693055
[TBL] [Abstract][Full Text] [Related]
7. Indurated Plaques on the Legs: Think Lymphoma.
Watts-Santos A; Cuellar-Barboza A; Ramos-Cavazos CJ; Villarreal-Martinez A; Ocampo-Candiani J; Herz-Ruelas ME
Acta Dermatovenerol Croat; 2021 Jul; 29(2):114-115. PubMed ID: 34477080
[TBL] [Abstract][Full Text] [Related]
8. Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type on the Dorsal Foot in a Senior Woman: A Case Report.
Kelly J; Mirkin G; Yim J; Hao X
J Am Podiatr Med Assoc; 2022; 112(6):. PubMed ID: 36525320
[TBL] [Abstract][Full Text] [Related]
9. THERAPY-RELATED T/MYELOID MIXED PHENOTYPE ACUTE LEUKEMIA IN A PATIENT TREATED WITH CHEMOTHERAPY FOR CUTANEOUS DIFFUSE LARGE B CELL LYMPHOMA.
Roberts E; Oncale M; Safah H; Schmieg J
J La State Med Soc; 2016; 168(1):16-20. PubMed ID: 26986862
[TBL] [Abstract][Full Text] [Related]
10. Primary Cutaneous B-Cell Lymphomas: An Update.
Vitiello P; Sica A; Ronchi A; Caccavale S; Franco R; Argenziano G
Front Oncol; 2020; 10():651. PubMed ID: 32528871
[TBL] [Abstract][Full Text] [Related]
11. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas.
Willemze R; Cerroni L; Kempf W; Berti E; Facchetti F; Swerdlow SH; Jaffe ES
Blood; 2019 Apr; 133(16):1703-1714. PubMed ID: 30635287
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous B-cell lymphomas- clinical and histopathologic features, differential diagnosis, and treatment.
Chen ST; Barnes J; Duncan L
Semin Cutan Med Surg; 2018 Mar; 37(1):49-55. PubMed ID: 29719020
[TBL] [Abstract][Full Text] [Related]
13. A Single-Arm Phase II Trial of Lenalidomide in Relapsing or Refractory Primary Cutaneous Large B-Cell Lymphoma, Leg Type.
Beylot-Barry M; Mermin D; Maillard A; Bouabdallah R; Bonnet N; Duval-Modeste AB; Mortier L; Ingen-Housz-Oro S; Ram-Wolff C; Barete S; Dalle S; Maubec E; Quereux G; Templier I; Bagot M; Grange F; Joly P; Vergier B; Vially PJ; Gros A; Pham-Ledard A; Frison E; Merlio JP
J Invest Dermatol; 2018 Sep; 138(9):1982-1989. PubMed ID: 29596904
[TBL] [Abstract][Full Text] [Related]
14. The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
Swerdlow SH; Campo E; Pileri SA; Harris NL; Stein H; Siebert R; Advani R; Ghielmini M; Salles GA; Zelenetz AD; Jaffe ES
Blood; 2016 May; 127(20):2375-90. PubMed ID: 26980727
[TBL] [Abstract][Full Text] [Related]
15. Excellent Outcome of Immunomodulation or Bruton's Tyrosine Kinase Inhibition in Highly Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
Gupta E; Accurso J; Sluzevich J; Menke DM; Tun HW
Rare Tumors; 2015 Dec; 7(4):6067. PubMed ID: 26788279
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]